(571) 447-5500

EAS Blog

EAS Independent Consultants and staff provide in-depth regulatory expertise and authoritative reporting on a variety of compliance requirements for industries that EAS serves. Our experts break down complicated topics into easily understandable summaries and analysis. Subscribe to our newsletter and receive these monthly updates directly in your in-box.

FDA Intends to Extend Compliance Date for Food Traceability Rule

FDA Intends to Extend Compliance Date for Food Traceability Rule

Constituent Update March 20, 2025 View on the FDA WebsiteToday, the U.S. Food and Drug Administration (FDA) is announcing its intention to extend the compliance date for the Food Traceability Rule (the “final rule”) by 30 months. The FDA intends to extend the compliance date using appropriate...

read more
HHS, FDA Announce Chemical Contaminants Transparency Tool for Foods

HHS, FDA Announce Chemical Contaminants Transparency Tool for Foods

For Immediate Release: March 20, 2025View on FDA WebsiteToday, under the leadership of U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr., the U.S. Food and Drug Administration unveiled the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database...

read more
Understanding the Role of Your U.S. Agent

Understanding the Role of Your U.S. Agent

Foreign entities who operate in US FDA-regulated industries must have an appointed FDA US agent before they can import products into the US. At a minimum these FDA US agents provide the most basic of required services. However, agents with relevant experience and knowledge can provide much more.

read more
Salmonella Framework for Raw Poultry Products

Salmonella Framework for Raw Poultry Products

by Dionne S. Meehan, EAS Consulting Group Independent ConsultantOn August 7, 2024, the United States Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) published its updated “Salmonella Framework for Raw Poultry Products” consisting of a proposed rule and proposed...

read more
2024 CARES Act Drug Volume Reporting Reminder

2024 CARES Act Drug Volume Reporting Reminder

Final reminder that CARES volume reports for 2024 are due no later than 31 March 2025 for all registered drug establishments. Do remember how vital it is to ensure all NDC listings reflect their correct status. The FDA will expect volume information for an NDC no longer manufactured that has not...

read more
Drug and Device Corner February 2025

Drug and Device Corner February 2025

Reminder that CARES volume reports for 2024 are due no later than 31 March 2025. If you need assistance with the process, EAS is here to help.The FDA has updated the OTC MONOGRAPHS @ FDA website’s OTC Monograph Resources section.  This includes a digital Catalogue of Pre-OMUFA Documents dataset in...

read more
Food and Dietary Supplement Labeling: What Comes Next?

Food and Dietary Supplement Labeling: What Comes Next?

Labeling of food and dietary supplements in the United States involve several aspects and each must be approached with careful consideration. Regulatory, scientific, and business decisions need to be considered when working on labels’ mandatory elements and claims. The FDA released in December...

read more
Food Standards Australia New Zealand

Food Standards Australia New Zealand

Food Standards Australia New Zealand (FSANZ) has compiled all 80 Standards and 29 Schedules of the Code into a single, easy-to-search and navigate guidance document. While an obvious resource for Australian and New Zealand based food businesses, it is also a great resource for businesses exporting...

read more
Cosmetic Registration and Listing Requirement Reminder

Cosmetic Registration and Listing Requirement Reminder

Now that we have entered the first year post cosmetic registration and listing requirements, it’s a good time to review your records and make sure you are prepared for your update / renewal process. For facility registrations, an update should be submitted within 60 days of any changes to the...

read more
Audits: Internal, Regulatory, and Mock…. Oh, My!

Audits: Internal, Regulatory, and Mock…. Oh, My!

Audits come in a variety of types, but the three main audit types that will be covered here are Regulatory Audits, Internal Audits, and Mock Audits. The ways a company handles, conducts and views these three categories of inspections will set them up for success. Read more of Jeb Hunter's featured...

read more
Regulatory Freeze Executive Order

Regulatory Freeze Executive Order

Effective January 20, 2025, President Trump issued a Regulatory Freeze Executive Order, which will have a direct impact on regulated industries. The regulatory freeze order, consistent with the actions of previous incoming administrations, effectively halts any rulemaking or similar regulatory...

read more
Drug and Device Corner January 2025

Drug and Device Corner January 2025

Effective January 20, 2025, The President issued a Regulatory Freeze Executive Order, which will have a direct impact on regulated industries. The regulatory freeze order, consistent with the actions of previous incoming administrations, effectively halts any rulemaking or similar regulatory...

read more
Regulatory Freeze Executive Order

Regulatory Freeze Executive Order

Effective January 20, 2025, President Trump issued a Regulatory Freeze Executive Order, which will have a direct impact on regulated industries. Regulatory Freeze The regulatory freeze order, consistent with the actions of previous incoming administrations, effectively halts any rulemaking or...

read more
FDA Issues Proposed Rule on Front-of-Package Nutrition Labeling

FDA Issues Proposed Rule on Front-of-Package Nutrition Labeling

On January 14, 2025, the U.S. Food and Drug Administration (FDA) announced a proposed rule to require a front-of-package (FOP) nutrition label on most packaged foods to provide accessible, at-a-glance information to help consumers quickly and easily identify how foods can be part of a healthy...

read more
Considerations for Complying with 21 CFR 211.110

Considerations for Complying with 21 CFR 211.110

January 2025 Docket Number: FDA-2024-D-5374 Issued by: Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Veterinary MedicineThis guidance, when finalized, will describe considerations for complying with the requirements in 21 CFR 211.110 to ensure...

read more
Pet Supplement Industry on the Rise

Pet Supplement Industry on the Rise

Recent survey reports indicate that supplements for pets have reached US sales of nearly $3 billion, with dog and cat supplements comprising of approximately 75% and 20% of the total, respectively. The growing pet supplement market is aimed at pet health and wellness, particularly for issues like mobility, skin and coat health, and anxiety. Survey reports specifically indicate that hip and joint supplements are the most frequently type of supplement purchased.

read more
Claims Substantiation Seminar

Claims Substantiation Seminar

This two-hour training will be a scientific dive into the regulatory requirement of claims substantiation. Several topics including the following will be discussed along with real case examples: which types of evidence are available and where to find them; what are high quality and low quality evidence; when is the evidence irrelevant to the claim being made; and how to write claims that can be substantiated.

read more
Drug and Device Corner December 2024

Drug and Device Corner December 2024

The FDA issued a final rule establishing requirements for a nonprescription drug product with an Additional Condition for Nonprescription Use (ACNU). This new marketing pathway will allow the sale of a nonprescription drug product directly to a consumer once the user completes an ACNU...

read more